395 related articles for article (PubMed ID: 26974154)
1. RNA-binding protein IGF2BP3 targeting of oncogenic transcripts promotes hematopoietic progenitor proliferation.
Palanichamy JK; Tran TM; Howard JM; Contreras JR; Fernando TR; Sterne-Weiler T; Katzman S; Toloue M; Yan W; Basso G; Pigazzi M; Sanford JR; Rao DS
J Clin Invest; 2016 Apr; 126(4):1495-511. PubMed ID: 26974154
[TBL] [Abstract][Full Text] [Related]
2. Stat5-deficient hematopoiesis is permissive for Myc-induced B-cell leukemogenesis.
Wang Z; Medrzycki M; Bunting ST; Bunting KD
Oncotarget; 2015 Oct; 6(30):28961-72. PubMed ID: 26338970
[TBL] [Abstract][Full Text] [Related]
3. The RNA-binding protein IGF2BP3 is critical for MLL-AF4-mediated leukemogenesis.
Tran TM; Philipp J; Bassi JS; Nibber N; Draper JM; Lin TL; Palanichamy JK; Jaiswal AK; Silva O; Paing M; King J; Katzman S; Sanford JR; Rao DS
Leukemia; 2022 Jan; 36(1):68-79. PubMed ID: 34321607
[TBL] [Abstract][Full Text] [Related]
4. MLL fusion-driven activation of CDK6 potentiates proliferation in MLL-rearranged infant ALL.
van der Linden MH; Willekes M; van Roon E; Seslija L; Schneider P; Pieters R; Stam RW
Cell Cycle; 2014; 13(5):834-44. PubMed ID: 24736461
[TBL] [Abstract][Full Text] [Related]
5. Identification of characteristic IGF2BP expression patterns in distinct B-ALL entities.
Stoskus M; Gineikiene E; Valceckiene V; Valatkaite B; Pileckyte R; Griskevicius L
Blood Cells Mol Dis; 2011 Apr; 46(4):321-6. PubMed ID: 21414819
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of high c-MYC and low MYCBP2 expression and their association with Ikaros dysfunction in adult acute lymphoblastic leukemia.
Ge Z; Guo X; Li J; Hartman M; Kawasawa YI; Dovat S; Song C
Oncotarget; 2015 Dec; 6(39):42300-11. PubMed ID: 26517351
[TBL] [Abstract][Full Text] [Related]
7. IGF2BP3 Modulates the Interaction of Invasion-Associated Transcripts with RISC.
Ennajdaoui H; Howard JM; Sterne-Weiler T; Jahanbani F; Coyne DJ; Uren PJ; Dargyte M; Katzman S; Draper JM; Wallace A; Cazarez O; Burns SC; Qiao M; Hinck L; Smith AD; Toloue MM; Blencowe BJ; Penalva LO; Sanford JR
Cell Rep; 2016 May; 15(9):1876-83. PubMed ID: 27210763
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of LIN28B-induced hematopoietic reprogramming by IGF2BP3.
Wang S; Chim B; Su Y; Khil P; Wong M; Wang X; Foroushani A; Smith PT; Liu X; Li R; Ganesan S; Kanellopoulou C; Hafner M; Muljo SA
Genes Dev; 2019 Aug; 33(15-16):1048-1068. PubMed ID: 31221665
[TBL] [Abstract][Full Text] [Related]
9. RNA-binding protein PUM2 promotes T-cell acute lymphoblastic leukemia via competitively binding to RBM5 3'UTR with miR-28-5p.
Bai T; Liu N
Eur J Haematol; 2023 May; 110(5):498-509. PubMed ID: 36536516
[TBL] [Abstract][Full Text] [Related]
10. Up-regulated A20 promotes proliferation, regulates cell cycle progression and induces chemotherapy resistance of acute lymphoblastic leukemia cells.
Chen S; Xing H; Li S; Yu J; Li H; Liu S; Tian Z; Tang K; Rao Q; Wang M; Wang J
Leuk Res; 2015 Sep; 39(9):976-83. PubMed ID: 26159495
[TBL] [Abstract][Full Text] [Related]
11. Targeting IGF2BP3 enhances antileukemic effects of menin-MLL inhibition in MLL-AF4 leukemia.
Lin TL; Jaiswal AK; Ritter AJ; Reppas J; Tran TM; Neeb ZT; Katzman S; Thaxton ML; Cohen A; Sanford JR; Rao DS
Blood Adv; 2024 Jan; 8(2):261-275. PubMed ID: 38048400
[TBL] [Abstract][Full Text] [Related]
12. Oncofetal protein IGF2BP3 facilitates the activity of proto-oncogene protein eIF4E through the destabilization of EIF4E-BP2 mRNA.
Mizutani R; Imamachi N; Suzuki Y; Yoshida H; Tochigi N; Oonishi T; Suzuki Y; Akimitsu N
Oncogene; 2016 Jul; 35(27):3495-502. PubMed ID: 26522719
[TBL] [Abstract][Full Text] [Related]
13. Focused CRISPR-Cas9 genetic screening reveals USO1 as a vulnerability in B-cell acute lymphoblastic leukemia.
Jaiswal AK; Truong H; Tran TM; Lin TL; Casero D; Alberti MO; Rao DS
Sci Rep; 2021 Jun; 11(1):13158. PubMed ID: 34162911
[TBL] [Abstract][Full Text] [Related]
14. The role of c-Myc-RBM38 loop in the growth suppression in breast cancer.
Li XX; Shi L; Zhou XJ; Wu J; Xia TS; Zhou WB; Sun X; Zhu L; Wei JF; Ding Q
J Exp Clin Cancer Res; 2017 Apr; 36(1):49. PubMed ID: 28399911
[TBL] [Abstract][Full Text] [Related]
15. miR-196b/miR-1290 participate in the antitumor effect of resveratrol via regulation of IGFBP3 expression in acute lymphoblastic leukemia.
Zhou W; Wang S; Ying Y; Zhou R; Mao P
Oncol Rep; 2017 Feb; 37(2):1075-1083. PubMed ID: 28000876
[TBL] [Abstract][Full Text] [Related]
16. Aberrant Notch Signaling in the Bone Marrow Microenvironment of Acute Lymphoid Leukemia Suppresses Osteoblast-Mediated Support of Hematopoietic Niche Function.
Wang W; Zimmerman G; Huang X; Yu S; Myers J; Wang Y; Moreton S; Nthale J; Awadallah A; Beck R; Xin W; Wald D; Huang AY; Zhou L
Cancer Res; 2016 Mar; 76(6):1641-52. PubMed ID: 26801976
[TBL] [Abstract][Full Text] [Related]
17. ZFP36L1 promotes monocyte/macrophage differentiation by repressing CDK6.
Chen MT; Dong L; Zhang XH; Yin XL; Ning HM; Shen C; Su R; Li F; Song L; Ma YN; Wang F; Zhao HL; Yu J; Zhang JW
Sci Rep; 2015 Nov; 5():16229. PubMed ID: 26542173
[TBL] [Abstract][Full Text] [Related]
18. Low-level GATA2 overexpression promotes myeloid progenitor self-renewal and blocks lymphoid differentiation in mice.
Nandakumar SK; Johnson K; Throm SL; Pestina TI; Neale G; Persons DA
Exp Hematol; 2015 Jul; 43(7):565-77.e1-10. PubMed ID: 25907033
[TBL] [Abstract][Full Text] [Related]
19. Global analysis of RNA-binding proteins identifies a positive feedback loop between LARP1 and MYC that promotes tumorigenesis.
Desi N; Tong QY; Teh V; Chan JJ; Zhang B; Tabatabaeian H; Tan HQ; Kapeli K; Jin W; Lim CY; Kwok ZH; Tan HT; Wang S; Siew BE; Lee KC; Chong CS; Tan KK; Yang H; Kappei D; Yeo GW; Chung MCM; Tay Y
Cell Mol Life Sci; 2022 Feb; 79(3):147. PubMed ID: 35195778
[TBL] [Abstract][Full Text] [Related]
20. YBX1 is required for maintaining myeloid leukemia cell survival by regulating BCL2 stability in an m6A-dependent manner.
Feng M; Xie X; Han G; Zhang T; Li Y; Li Y; Yin R; Wang Q; Zhang T; Wang P; Hu J; Cheng Y; Gao Z; Wang J; Chang J; Cui M; Gao K; Chai J; Liu W; Guo C; Li S; Liu L; Zhou F; Chen J; Zhang H
Blood; 2021 Jul; 138(1):71-85. PubMed ID: 33763698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
